A randomized trial of sorbinil, an aldose reductase inhibitor, in diabetic retinopathy. Sorbinil Retinopathy Trial Research Group

Archives of Ophthalmology

Abstract

A total of 497 patients aged 18 to 56 years with insulin-dependent diabetes mellitus for 1 to 15 years were randomly assigned to take oral sorbinil or placebo and followed up for a median of 41 months. The percentage of patients whose retinopathy severity grade at maximum follow-up had worsened by two or more levels was not significantly different between the two treatment groups (28% in the sorbinil group and 32% in the placebo group, P = .344). The number of microaneurysms increased at a slightly slower rate in the sorbinil group than in the placebo group, with statistically significant differences at 21 (P = .046) and 30 (P = .039) months but not at the maximum follow-up (P = .156). About 7% of the patients assigned sorbinil developed a hypersensitivity reaction in the first 3 months. On the basis of these results, it is unlikely that sorbinil administered at a dosage of 250 mg daily for 3 years has a clinically important effect on the course of retinopathy in adults with insulin-dependent diabetes of moderate duration. Our data are consistent, however, with a slightly slower progression rate in the microaneurysm count among patients assigned to take sorbinil, a finding of uncertain clinical importance.

Associated Clinical Trials

Citations

Jul 1, 1992·Diabetes/metabolism Reviews·J G Cunha-Vaz
Jul 1, 1995·Diabetes/metabolism Reviews·R L Engerman, T S Kern
Jan 22, 1998·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·H NeuenschwanderP F Kador
Jan 5, 2002·Expert Opinion on Investigational Drugs·R A Kowluru, A Kennedy
Jan 6, 2004·International Ophthalmology Clinics·John B Christoforidis, Donald J D'Amico
Mar 16, 2004·Pediatric Diabetes·C Giusti
Oct 30, 2004·Seminars in Ophthalmology·F BandelloM Ambesi
May 1, 2009·Nature Reviews. Drug Discovery·Nigel A CalcuttAnn Marie Schmidt
Feb 8, 2011·Antioxidants & Redox Signaling·Tiffany Frey, David A Antonetti
May 4, 2011·Diabetes, Obesity & Metabolism·M PortaF Mazzaglia
Aug 3, 2013·Clinical Medicine : Journal of the Royal College of Physicians of London·Michael Andrew Williams, Usha Chakravarthy
Jun 1, 2010·Journal of Diabetes Investigation·Munehiro KitadaGeorge L King
Jan 1, 1993·Acta Diabetologica·M La SelvaG M Molinatti
May 4, 1995·The New England Journal of Medicine·C M Clark, D A Lee
Sep 30, 1995·Statistics in Medicine·G Marshall, R H Jones
Jan 1, 1994·The British Journal of Ophthalmology·T A GardinerD B Archer
Nov 25, 2003·The Annals of Pharmacotherapy·Stephen M SetterClifton J Cahoon
Sep 29, 2004·Diabetes Care·Donald S FongRonald Klein
Jul 12, 2003·Eye·M Donaldson, P M Dodson
Jul 26, 2008·Reviews in Endocrine & Metabolic Disorders·Sally A Madsen-Bouterse, Renu A Kowluru
Jun 7, 2005·Expert Opinion on Emerging Drugs·Grant M Comer, Thomas A Ciulla
Oct 1, 2010·Biometrics·Bernard Rosner, Robert J Glynn
May 14, 2016·Expert Opinion on Drug Delivery·Jayabalan NirmalRupesh Agrawal
Jan 1, 1991·Documenta Ophthalmologica. Advances in Ophthalmology·A TrompJ J van Doormaal
Jan 1, 1993·Diabetic Medicine : a Journal of the British Diabetic Association·H M Krans
Jan 1, 1994·Documenta Ophthalmologica. Advances in Ophthalmology·J M van GervenJ A van Best
Nov 13, 2003·Expert Opinion on Emerging Drugs·Matthew A SpeicherLinda Pratt
Dec 13, 2000·Diabetes/metabolism Research and Reviews·S ChakrabartiS Chen
May 15, 1993·Hospital Practice·F L Ferris
Nov 4, 2004·Current Opinion in Ophthalmology·Grant M Comer, Thomas A Ciulla
Feb 22, 2008·Experimental Diabetes Research·Zia A Khan, Subrata Chakrabarti
Aug 26, 1999·The New England Journal of Medicine·F L FerrisL M Aiello

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.